Some interesting insights on off-label use - stroll to the bottom for a summary if you are interested but haven’t got time; otherwise, look for the framework that is useful for thinking about this from a physician’s point of view, which is how the regulator would like to “adopt” when thinking of the topic:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998554/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538391/
https://www.fda.gov/drugs/fdas-labeling-resources-human-prescription-drugs/prescribing-information-resources
(labeling resources page which includes a video to guide industry participants whose job it is to compile prescription information)
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label
Some interesting insights on off-label use - stroll to the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.020(2.04%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.01 | 99.0¢ | $578.1K | 579.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 37539 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 23469 | 8 |
View Market Depth
| Last trade - 10.16am 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |